S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
OTCMKTS:MRMD

MariMed (MRMD) Stock Price, News & Analysis

$0.26
-0.01 (-3.65%)
(As of 03/28/2024 ET)
Today's Range
$0.26
$0.29
50-Day Range
$0.20
$0.38
52-Week Range
$0.20
$0.55
Volume
369,441 shs
Average Volume
514,478 shs
Market Capitalization
$99.06 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
MRMD stock logo

About MariMed Stock (OTCMKTS:MRMD)

MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature's Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty's Eddies brand and ice creams under Emack & Bolio's brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.

MRMD Stock Price History

MRMD Stock News Headlines

Crypto Market Preps For Trillions Worth of Inflows!
Bitcoin is rapidly approaching new ALL-TIME HIGHS… The market is buzzing after recent approval of spot Bitcoin exchange-traded funds (ETF). Top analysts predict these ETFs will attract trillions of dollars worth of inflows over the next few years… And as Bitcoin rallies, we could see other smaller coins rise to heights never seen before.
Grab Your Free Bitcoin Today!
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
MariMed's Earnings: A Preview
MariMed Closes $58.7 Million Debt Refinancing
See More Headlines
Receive MRMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MariMed and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/15/2021
Today
3/28/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medicinals & botanicals
Sub-Industry
N/A
Current Symbol
OTCMKTS:MRMD
Fax
N/A
Employees
643
Year Founded
N/A

Profitability

Net Income
$-16,030,000.00
Pretax Margin
-4.44%

Debt

Sales & Book Value

Annual Sales
$148.60 million
Cash Flow
$0.03 per share
Book Value
$0.19 per share

Miscellaneous

Free Float
298,041,000
Market Cap
$102.22 million
Optionable
Not Optionable
Beta
2.85
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. Jon R. Levine (Age 59)
    Co-Founder, CEO, Interim CFO, President, Secretary, Treasurer & Director
    Comp: $481.74k
  • Mr. Timothy Shaw (Age 46)
    Chief Operating Officer
    Comp: $445.86k
  • Mr. Jonathan W. Rider (Age 59)
    Chief Information Officer
  • Mr. Steve Wayne West
    Vice President of Investor Relations
  • Mr. Howard Schacter
    Chief Communications Officer
  • Ms. Sara Gullickson (Age 39)
    Vice President of Marketing
  • Mr. Ryan Crandall
    Chief Revenue Officer
  • Mr. Charles Holt Finnie
    Chief Strategy Officer

MRMD Stock Analysis - Frequently Asked Questions

How have MRMD shares performed in 2024?

MariMed's stock was trading at $0.2748 at the beginning of 2024. Since then, MRMD shares have decreased by 3.9% and is now trading at $0.2641.
View the best growth stocks for 2024 here
.

Are investors shorting MariMed?

MariMed saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 53,200 shares, an increase of 198.9% from the February 29th total of 17,800 shares. Based on an average daily trading volume, of 1,346,700 shares, the short-interest ratio is presently 0.0 days.
View MariMed's Short Interest
.

How were MariMed's earnings last quarter?

MariMed Inc. (OTCMKTS:MRMD) released its quarterly earnings data on Monday, November, 15th. The company reported $0.01 earnings per share for the quarter. The firm had revenue of $33.21 million for the quarter. MariMed had a negative net margin of 10.79% and a negative trailing twelve-month return on equity of 1.84%.

What guidance has MariMed issued on next quarter's earnings?

MariMed updated its FY 2024 earnings guidance on Wednesday, March, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $156.0 million-$159.0 million, compared to the consensus revenue estimate of $173.8 million.

What other stocks do shareholders of MariMed own?
How do I buy shares of MariMed?

Shares of MRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:MRMD) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners